[Nutrition and age-related macular degeneration]
- PMID: 15602406
[Nutrition and age-related macular degeneration]
Abstract
The nutritional factors involved in the pathogenesis of age-related macular degeneration (AMD) include antioxidants or antioxidant cofactors: vitamins A, C, etc.; zinc, etc.; anti-free-radicals such as beta-carotene and carotenoids, including lutein and zeaxanthin; micronutrients protecting from blue light such as lutein and zeaxanthin; and finally components of the membranes of the photoreceptors docosahexaenoic acid (DHA). These nutritional factors are closely related to environmental risk factors such as smoking and chronic blue light exposure. Although the experimental and epidemiological data are concordant and coherent, the protective role of these micronutrients is not clearly established, mainly because there are very few clinical studies. However, a first observation study showed positive effects at stages 3 and 4 of AMD. Report #8 of the Age-Related Eye Disease Study (AREDS) provides important results for preventing complications of AMD (secondary prevention), and the cocktail of micronutrients proposed even encourages complementary studies on, for example, lutein and zeaxanthin instead of beta-carotene. The outcome of observation studies including a supplementation of long-chain polyunsaturated fatty acids (PUFA) of the omega-3 family (DHA) is also important, as it addresses primary prevention of the disease. A supplementation of omega-3 PUFAs could be proposed to certain subjects at risk for AMD for primary prevention and a supplementation with an antioxidant cocktail of micronutrients could be proposed to patients presenting AMD at stages 3 or 4 or to subjects with a nutritional imbalance. These conceivable supplementations are compatible with simple dietary advice. The supplements currently proposed could be optimized to increase their advantages. New research and new clinical studies are necessary to definitively validate these formulations in order to grant them an authentic drug status.
Similar articles
-
[Macular pigment and age-related macular degeneration. Clinical implications].Bull Soc Belge Ophtalmol. 2006;(301):15-22. Bull Soc Belge Ophtalmol. 2006. PMID: 17552428 French.
-
An ideal ocular nutritional supplement?Ophthalmic Physiol Opt. 2004 Jul;24(4):339-49. doi: 10.1111/j.1475-1313.2004.00218.x. Ophthalmic Physiol Opt. 2004. PMID: 15228513 Review.
-
[Vitamins for prevention of age related macular degeneration: efficacy and risk].Bull Soc Belge Ophtalmol. 2006;(301):33-6. Bull Soc Belge Ophtalmol. 2006. PMID: 17552430 Review. French.
-
Nutritional supplementation and age-related macular degeneration.Semin Ophthalmol. 2011 May;26(3):131-6. doi: 10.3109/08820538.2011.577131. Semin Ophthalmol. 2011. PMID: 21609225 Review.
-
[Micronutrients and their relevance for the eye--function of lutein, zeaxanthin and omega-3 fatty acids].Klin Monbl Augenheilkd. 2011 Jun;228(6):537-43. doi: 10.1055/s-0029-1245527. Epub 2010 Aug 25. Klin Monbl Augenheilkd. 2011. PMID: 20740395 Review. German.
Cited by
-
Combination therapy for choroidal neovascularisation.Drugs Aging. 2007;24(12):979-90. doi: 10.2165/00002512-200724120-00002. Drugs Aging. 2007. PMID: 18020531
-
The effect of age and cataract surgery on macular pigment optic density: a cross-sectional, comparative study.Graefes Arch Clin Exp Ophthalmol. 2014 Feb;252(2):213-8. doi: 10.1007/s00417-013-2424-2. Epub 2013 Jul 20. Graefes Arch Clin Exp Ophthalmol. 2014. PMID: 23873256
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical